Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone users

SUPER-Finland study, Elina Hietala, Anssi Solismaa, Markku Lähteenvuo, Ari V. Ahola-Olli, Katja Häkkinen, Kimmo Suokas, Erkki Isometsä, Jaana Suvisaari, Tuula Kieseppä, Minna Holm, Jari Tiihonen, Jouko Lönnqvist, Jarmo Hietala, Asko Wegelius, Kaisla Lahdensuo, Willehard Haaki, Olli Kampman, Aarno Palotie, Aija KyttäläAnders Kämpe, Annamari Tuulio-Henriksson, Auli Toivola, Benjamin Neale, Huei Yi Shen, Imre Västrik, Juha Veijola, Jussi Niemi-Pynttäri, Mark Daly, Noora Ristiluoma, Olli Pietiläinen, Risto Kajanne, Steven E. Hyman, Tarjinder Singh, Teemu Männynsalo, Tiina Paunio, Tuomas Jukuri

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article numbere54
JournalActa Neuropsychiatrica
Volume37
Number of pages11
ISSN0924-2708
DOIs
Publication statusPublished - 25 Mar 2025
MoE publication typeA1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© 2025 Cambridge University Press. All rights reserved.

Fields of Science

  • Antipsychotic Agents
  • Cytochrome P-450 CYP2D6
  • Pharmacogenetics
  • Psychotic Disorders
  • Treatment Adherence and Compliance
  • 3112 Neurosciences
  • 3124 Neurology and psychiatry

Cite this